Literature DB >> 10514442

Hereditary pancreatitis-associated mutation asn(21) --> ile stabilizes rat trypsinogen in vitro.

M Sahin-Tóth1.   

Abstract

Mutations Arg(117) --> His and Asn(21) --> Ile in human trypsinogen-I have been recently associated with hereditary pancreatitis (HP). The Arg(117) --> His substitution is believed to cause pancreatitis by stabilizing trypsin against autolytic degradation, while the mechanism of action of Asn(21) --> Ile has been unknown. In an effort to understand the effect(s) of this mutation, Thr(21) in the highly homologous rat trypsinogen-II was replaced with Asn or Ile, and the recombinant zymogens and their active trypsin forms were studied. Kinetic parameters of all three trypsins were comparable, and the active enzymes suffered autolysis at similar rates, indicating that neither catalytic properties nor proteolytic stability of trypsin are influenced by mutations at position 21. When incubated at pH 8.0, 37 degrees C, pure zymogens underwent autoactivation with concomitant trypsinolytic degradation in a Ca(2+)-dependent fashion. Thus, in the presence of 5 mM Ca(2+), autoactivation and digestion of the zymogens after Arg(117) and Lys(188) were observed, while in the presence of 1 mM EDTA autoactivation and cleavage at Lys(188) were reduced, and zymogenolysis at the Arg(117) site was enhanced. Overall rates of zymogen degradation in [Asn(21)]- and [Ile(21)]trypsinogens were higher in Ca(2+) than in EDTA, while [Thr(21)]trypsinogen demonstrated inverse characteristics. Remarkably, both in the presence and absence of Ca(2+), [Ile(21)]trypsinogen exhibited significantly higher stability against autoactivation and proteolysis than zymogens with Asn(21) or Thr(21). The observations suggest that autocatalytic trypsinogen degradation may be an important defense mechanism against excessive trypsin generation in the pancreas, and trypsinogen stabilization by the Asn(21) --> Ile mutation plays a role in the pathogenesis of HP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10514442     DOI: 10.1074/jbc.274.42.29699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Biochemical models of hereditary pancreatitis.

Authors:  Miklós Sahin-Tóth
Journal:  Endocrinol Metab Clin North Am       Date:  2006-06       Impact factor: 4.741

Review 2.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

Review 3.  Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Authors:  Niels Teich; Jonas Rosendahl; Miklós Tóth; Joachim Mössner; Miklós Sahin-Tóth
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

4.  Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis.

Authors:  Sebastian Gaiser; Jaroslaw Daniluk; Yan Liu; Lilian Tsou; Jun Chu; Woojin Lee; Daniel S Longnecker; Craig D Logsdon; Baoan Ji
Journal:  Gut       Date:  2011-04-06       Impact factor: 23.059

5.  Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors.

Authors:  Richárd Szmola; Zoltán Kukor; Miklos Sahin-Tóth
Journal:  J Biol Chem       Date:  2003-09-24       Impact factor: 5.157

6.  Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.

Authors:  Zsanett Jancsó; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2016-04-18       Impact factor: 5.157

7.  Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.

Authors:  Balázs Csaba Németh; Thomas Wartmann; Walter Halangk; Miklós Sahin-Tóth
Journal:  J Biol Chem       Date:  2013-06-27       Impact factor: 5.157

8.  Hereditary pancreatitis for the endoscopist.

Authors:  Milan R Patel; Amanda L Eppolito; Field F Willingham
Journal:  Therap Adv Gastroenterol       Date:  2013-03       Impact factor: 4.409

9.  Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen.

Authors:  Lena Selig; Ulrich Sack; Sebastian Gaiser; Günter Klöppel; Vuk Savkovic; Joachim Mössner; Volker Keim; Hans Bödeker
Journal:  BMC Gastroenterol       Date:  2006-10-27       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.